Published in J Neurol Sci on November 15, 2004
Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry (2007) 3.92
Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke (2011) 1.60
Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis (2014) 1.56
Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev (2010) 1.44
Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci (2013) 1.27
Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol (2008) 1.25
Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr Dis Treat (2008) 1.21
Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther (2009) 1.00
Rivastigmine in the treatment of Alzheimer's disease: an update. Clin Interv Aging (2007) 0.97
Vascular dementia. J Neurol Sci (2012) 0.96
High risk neurological gait syndrome and vascular dementia. J Neural Transm (Vienna) (2007) 0.94
The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease. Brain Behav (2013) 0.93
HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int (2015) 0.89
Modeling cognitive trajectories within longitudinal studies: a focus on older adults. J Am Geriatr Soc (2010) 0.88
Impact of aerobic exercise on neurobehavioral outcomes. Ment Health Phys Act (2013) 0.85
Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients. Clin Psychopharmacol Neurosci (2016) 0.85
Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure. J Neural Transm (Vienna) (2010) 0.83
Neuropsychological profile in a large group of heart transplant candidates. PLoS One (2011) 0.83
Endovascular middle cerebral artery occlusion in rats as a model for studying vascular dementia. Age (Dordr) (2006) 0.82
Psychiatric manifestations of neurologic disease: where are we headed? Dialogues Clin Neurosci (2007) 0.82
Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II. Neuroepidemiology (2010) 0.82
1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment. J Neurol Neurosurg Psychiatry (2013) 0.82
Longitudinal associations between physical and cognitive performance among community-dwelling older adults. PLoS One (2015) 0.81
Effects of differences in serum total homocysteine, folate, and vitamin B12 on cognitive impairment in stroke patients. BMC Neurol (2014) 0.80
Phobic anxiety and cognitive performance over 4 years among community-dwelling older women in the Nurses' Health Study. Am J Geriatr Psychiatry (2013) 0.79
Trajectory of Mobility Decline by Type of Dementia. Alzheimer Dis Assoc Disord (2016) 0.79
Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT (2014) 0.78
Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment. J Diabetes Metab (2014) 0.77
Cerebral Blood Flow Alterations as Assessed by 3D ASL in Cognitive Impairment in Patients with Subcortical Vascular Cognitive Impairment: A Marker for Disease Severity. Front Aging Neurosci (2016) 0.76
Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study. Neural Plast (2016) 0.76
Should the word 'dementia' be forgotten? J Cell Mol Med (2010) 0.75
TCF7L2 polymorphism and cognitive test performance in cardiovascular disease. Psychogeriatrics (2012) 0.75
When Rey-Osterrieth's Complex Figure Becomes a Church: Prevalence and Correlates of Graphic Confabulations in Dementia. Dement Geriatr Cogn Dis Extra (2011) 0.75
Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America. Front Aging Neurosci (2016) 0.75
Genetics of Vascular Dementia. Minerva Psichiatr (2010) 0.75
Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation. Behav Neurol (2017) 0.75
Vascular cognitive impairment, a cardiovascular complication. World J Psychiatry (2016) 0.75
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem (2004) 4.23
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14
Subcortical ischaemic vascular dementia. Lancet Neurol (2002) 3.32
Brain reserve and dementia: a systematic review. Psychol Med (2005) 3.24
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry (2012) 2.83
Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization. J Neurosci (2008) 2.77
The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health (2007) 2.54
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging (2008) 2.51
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain (2005) 2.51
Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke (2003) 2.42
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study. Lancet Neurol (2012) 2.22
Do white matter hyperintensities on MRI matter clinically? BMJ (2010) 2.07
The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage (2004) 2.04
Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study. BMJ (2010) 2.02
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriatr Psychiatry (2009) 1.89
Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology (2004) 1.88
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis (2010) 1.86
Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med (2006) 1.82
Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc (2007) 1.75
Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord (2011) 1.67
Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci (2011) 1.61
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol Aging (2007) 1.61
Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss? Neurosci Lett (2008) 1.60
The 10/66 Dementia Research Group's fully operationalised DSM-IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validation study. BMC Public Health (2008) 1.60
Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS One (2008) 1.59
Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord (2007) 1.59
Sex and symmetry differences in hippocampal volumetrics: before and beyond the opening of the crus of the fornix. Hippocampus (2006) 1.59
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry (2012) 1.57
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging (2002) 1.56
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. J Alzheimers Dis (2007) 1.54
Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol (2013) 1.54
Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry (2008) 1.54
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. J Alzheimers Dis (2012) 1.52
Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet (2010) 1.50
Neurochemical aftermath of amateur boxing. Arch Neurol (2006) 1.47
Mexican-American ethnicity and cognitive function: findings from an elderly southwestern sample. J Neuropsychiatry Clin Neurosci (2006) 1.45
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Prospective evaluation of pretreatment executive cognitive impairment and depression in patients referred for radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.39
The emperor has no clothes: dementia treatment on the eve of the aging era. J Am Geriatr Soc (2005) 1.39
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry (2007) 1.38
COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Ann Neurol (2007) 1.34
Factors related to perceived quality of life in patients with Alzheimer's disease: the patient's perception compared with that of caregivers. Int J Geriatr Psychiatry (2009) 1.32
Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord (2006) 1.31
White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage (2010) 1.30
Ageing and dementia in low and middle income countries-Using research to engage with public and policy makers. Int Rev Psychiatry (2008) 1.29
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol (2006) 1.29
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. J Alzheimers Dis (2009) 1.26
White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry (2006) 1.26
Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev (2009) 1.25
Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study. Cerebrovasc Dis (2009) 1.25
White matter hyperintensities and within-person variability in community-dwelling adults aged 60-64 years. Neuropsychologia (2007) 1.24
Memory training alters hippocampal neurochemistry in healthy elderly. Neuroreport (2003) 1.24
Cognitive generation of affect in bipolar depression: an fMRI study. Eur J Neurosci (2004) 1.21
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord (2004) 1.20
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease. Brain (2008) 1.20
Optimal weights for local multi-atlas fusion using supervised learning and dynamic information (SuperDyn): validation on hippocampus segmentation. Neuroimage (2011) 1.18
Complex mental activity and the aging brain: molecular, cellular and cortical network mechanisms. Brain Res Rev (2007) 1.17
Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One (2008) 1.17
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Differential features of burden between spouse and adult-child caregivers of patients with Alzheimer's disease: an exploratory comparative design. Int J Nurs Stud (2010) 1.16
Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke (2010) 1.16
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease. Neurology (2007) 1.16
Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol (2011) 1.15
Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study. J Neurol Neurosurg Psychiatry (2009) 1.15
Depression, disability and intermediate pathways: a review of longitudinal studies in elders. J Geriatr Psychiatry Neurol (2008) 1.15
The impact of medical illness on executive function. Psychosomatics (2005) 1.15
When more is less: associations between corpus callosum size and handedness lateralization. Neuroimage (2010) 1.14
Assessment of complex mental activity across the lifespan: development of the Lifetime of Experiences Questionnaire (LEQ). Psychol Med (2006) 1.14
Prevalence and risk factors of suspected elder abuse subtypes in people aged 75 and older. J Am Geriatr Soc (2009) 1.14
Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease. J Alzheimers Dis (2011) 1.14
Changing topological patterns in normal aging using large-scale structural networks. Neurobiol Aging (2010) 1.13
Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study. Stroke (2012) 1.13
Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord (2009) 1.12
A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol (2009) 1.12
Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord (2011) 1.12
An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. Neurosci Lett (2006) 1.11
Validation of a posturographic approach to monitor sleepiness. J Biomech (2010) 1.10
Within-occasion intraindividual variability and preclinical diagnostic status: is intraindividual variability an indicator of mild cognitive impairment? Neuropsychology (2005) 1.10
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull (2003) 1.10
Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology (2012) 1.10
The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2011) 1.09
Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. Int Psychogeriatr (2009) 1.09
The brain reserve hypothesis, brain atrophy and aging. Gerontology (2006) 1.09
Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. Brain (2014) 1.08
Corpus callosum size, reaction time speed and variability in mild cognitive disorders and in a normative sample. Neuropsychologia (2007) 1.07
Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID). Int J Geriatr Psychiatry (2004) 1.07
Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J Alzheimers Dis (2009) 1.07
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.06
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry (2006) 1.05
Cognitive generation of affect in hypomania: an fMRI study. Bipolar Disord (2004) 1.05
White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke (2012) 1.05
Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study. Stroke (2010) 1.05
MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study. Cerebrovasc Dis (2009) 1.04